(19)

(11)

EP 4 280 945 A1

(12)

(43) Date of publication: 29.11.2023 Bulletin 2023/48 (21) Application number: 22716618.8 (22) Date of filing: 18.03.2022

(51) International Patent Classification (IPC):  A61B 5/021(2006.01) G16H 50/30(2018.01) A61B 5/022(2006.01) A61B 5/029(2006.01) A61B 5/00(2006.01) A61B 5/0215(2006.01) A61B 5/024(2006.01) A61B 5/08(2006.01) (52) Cooperative Patent Classification (CPC): A61B 5/7275; A61B 5/02108; A61B 5/7267; A61B 5/02241; A61B 5/0215; A61B 5/024; A61B 5/029; A61B 5/0816; A61B 5/746; A61B 5/4824; G16H 50/20 (86) International application number: PCT/US2022/020988 (87) International publication number: WO 2022/203965 (29.09.2022 Gazette 2022/39)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 24.03.2021 US 202163165702 P (71) Applicant: Edwards Lifesciences Corporation Irvine, CA 92614-5688 (US)	(72) Inventors: LEE, Christine Long Beach, CA 90814 (US) AL HATIB, Feras Irvine, CA 92614 (US) POTES BLANDON, Cristhian, M. Irvine, CA 92614 (US) MOSES, Kevin, James Irvine, CA 92614 (US) SZYMAN, Catherine, M. Irvine, CA 92614 (US) (74) Representative: Venner, Julia Ann et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL London WC1X 8NL (GB)